Véronique Rogemond

Title: The Innovative Contributions of Véronique Rogemond

Introduction

Véronique Rogemond is a notable inventor based in Lyons, France. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of cancers and paraneoplastic neurological syndromes. With a total of 2 patents, his work is paving the way for advancements in cancer detection and treatment.

Latest Patents

Rogemond's latest patents focus on the use of a novel human ULIP6/CRMP protein. The first patent describes the diagnosis of cancers and paraneoplastic neurological syndromes using a purified polypeptide known as ULIP6. This polypeptide comprises the amino acid sequence SEQ ID No. 2, along with its nucleic acid sequences. The patent also includes antibodies to the polypeptide and methods for diagnosing paraneoplastic neurological syndromes and the early detection of cancerous tumors. The second patent further elaborates on the use of the ULIP6 protein in the diagnosis and treatment of these medical conditions.

Career Highlights

Véronique Rogemond is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research and development. His work has garnered attention for its potential impact on early cancer diagnosis and treatment strategies.

Collaborations

Rogemond collaborates with esteemed colleagues such as Michèle Aguera and Jean-Christophe Antoine. Their combined expertise contributes to the innovative research being conducted in the field of medical diagnostics.

Conclusion

Véronique Rogemond's contributions to the field of cancer diagnosis and treatment through his innovative patents highlight the importance of research in improving medical outcomes. His work continues to inspire advancements in the medical community.